Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Thrombosis

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Thrombosis in 2 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.

Research Excerpts

ExcerptRelevanceReference
"In a model of fatal pulmonary thromboembolism induced by intravenous injection of ADP (300 micrograms/g), YC-1 was effective in reducing mortality when administered intraperitoneally at doses of 10-30 micrograms/g."1.30YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. ( Ko, FN; Kuo, SC; Lee, FY; Teng, CM; Wu, CC, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cwiklicki, A1
Rehse, K1
Teng, CM1
Wu, CC1
Ko, FN1
Lee, FY1
Kuo, SC1

Other Studies

2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Thrombosis

ArticleYear
Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
    Archiv der Pharmazie, 2004, Volume: 337, Issue:3

    Topics: Animals; Fibrinolytic Agents; Guanylate Cyclase; Indazoles; Lasers; Phosphoric Diester Hydrolases; P

2004
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    European journal of pharmacology, 1997, Feb-12, Volume: 320, Issue:2-3

    Topics: Adenosine Diphosphate; Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Disease Models, A

1997